Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF)

Tilburg University

Status

Withdrawn

Conditions

Heart Failure

Treatments

Behavioral: Medication Adherence Support System (MASS)

Study type

Interventional

Funder types

Other

Identifiers

NCT01347528

UVT MP 002

Details and patient eligibility

About

TELEMED-HF is a randomized, controlled clinical intervention trial designed to: (1) examine the efficacy of an electronic Medication Adherence Support System (MASS) in improving and monitoring patients' medication adherence; to (2) i determine the effect of medication adherence on hospitalization and health care consumption.

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Stable systolic heart failure
New York Heart Association functional class II-III, with a decreased pump function (left ventricular ejection fraction (LVEF) <45%)
Titrated to the most optimal doses of ACE-inhibitor or Angiotensin Receptor Blocker, and beta-blocker
Receiving stable doses of at least 3 heart failure medications (at multiple times during the day) for 1 month with no plans to add or adjust heart failure medications or titrate further in the immediate future.

Exclusion criteria

Age younger than 50 years
Diastolic heart failure (intact pump function)
Myocardial infarction, invasive treatment (percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)), or hospitalization within 1 month prior to inclusion
Life-threatening comorbid conditions (e.g., cancer)
Diminished mental capacities (suspected cognitive decline will be confirmed by a mini mental state examination (MMSE))
History of psychiatric disorders apart from affective disorders (depression and anxiety disorders)